3//SEC Filing
BCLS II Equity Opportunities, LP 3
Accession 0000950170-24-005896
CIK 0001707502other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 7:23 PM ET
Size
6.5 KB
Accession
0000950170-24-005896
Insider Transaction Report
Form 3
BCLS II Equity Opportunities GP, LLC
10% Owner
Holdings
- 904,160(indirect: See footnotes)
Common Stock
BCLS II Equity Opportunities, LP
10% Owner
Holdings
- 904,160(indirect: See footnotes)
Common Stock
Footnotes (2)
- [F1]Represents 904,160 shares of Common Stock purchased by BCLS II Equity Opportunities, LP ("BCLS II Equity") directly from the Issuer in a private placement that closed on January 11, 2024.
- [F2]BCLS II Equity Opportunities GP, LLC ("BCLS II Equity GP") is the general partner of BCLS II Equity. As a result, BCLS II Equity GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Equity. BCLS II Equity GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001814474
Filing Metadata
- Form type
- 3
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 7:23 PM ET
- Size
- 6.5 KB